- Founded
- 2018
- Employees
- 30
- Total Funding
- $280M
Founded by Ronald G. Crystal in 2018.
About Lexeo Therapeutics
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine.
Leadership at Lexeo Therapeutics
The team at the top of the org chart.
R. Nolan Townsend
CEO
39 reports
Paul B. McCormac
Chief Technical Officer
4 reports
Ronald Crystal
Founder & Chief Scientific Adviser
Eric Adler
Chief Scientific Officer
3 reports
Jenny Robertson
Advisor
1 report
Jenny Speer
Vice President, People Experience
2 reports
Joslyn Arnon Crowe
Patient Engagement & Advocacy
Vivian Hwang
Executive Assistant To The CEO
Sandi See Tai
Chief Development Officer
10 reports
Board
Steven Altschuler
Chairman
Bernard Davitian
Board Member
Mette Kirstine Agger
Board Member
Paula H. J. Cholmondeley
Board Member
Reinaldo Diaz
Board Member
Gene Yeo
Scientific Advisor
Open Jobs at Lexeo Therapeutics (7)
- Lexeo Therapeutics · New York, New York · 2moFull-time
- Lexeo Therapeutics · New York, New York · 3moFull-time
- Lexeo Therapeutics · New York, New York · 3moFull-time
- Lexeo Therapeutics · New York, New York · 3moFull-time
- Lexeo Therapeutics · New York, New York · 4moFull-time
- Lexeo Therapeutics · New York, New York · 5moFull-time
- Lexeo Therapeutics · New York, New York · 7moFull-time
Similar companies hiring
Top employers in Biotechnology